NCI names 11 winners of its Cancer Clinical Investigator Team Leadership Awards

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

NCI recognized 11 investigators nationwide with its Cancer Clinical Investigator Team Leadership Awards.

The awards support clinical investigators at NCI-designated cancer centers who participate in NCI-funded clinical trials. Established in 2009, the awards are intended to help retain investigators in academic clinical research careers. The award provides partial salary support for 2 years for the recipient to engage in activities and efforts related to the award.

The 2015 recipients are:

  • Leora Horn, of Vanderbilt-Ingram Cancer Center
  • David Hyman, of Memorial Sloan-Kettering Cancer Center
  • Matthew Katz, of MD Anderson Cancer Center
  • Edward Kim, of UC Davis Comprehensive Cancer Center
  • Frederick Lansigan, of Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center
  • Charles Leath III, of University of Alabama at Birmingham Comprehensive Cancer Center
  • Elizabeth Plimack, of Fox Chase Cancer Center
  • Andrew Poklepovic, of Massey Cancer Center at Virginia Commonwealth University
  • Yvonne Saenger, of Columbia University’s Herbert Irving Comprehensive Cancer Center
  • Emma Scott, of Oregon Health & Science University Knight Cancer Institute
  • Liza Villaruz, of the University of Pittsburgh Cancer Institute

For details of the 2016 program announcement, open through Dec. 4, visit the NCI website.

YOU MAY BE INTERESTED IN

Secretary of the U.S. Department of Health and Human Services Robert F. Kennedy Jr. appeared before the House Energy and Commerce Subcommittee on Health to defend the HHS fiscal year 2026 budget proposal, and faced criticism from several Democratic lawmakers on what they described as a lack of transparency and scientific rigor in the agency’s recent decisions.

The full-scale Russian invasion of Ukraine has devastated the Ukrainian healthcare infrastructure, disrupting cancer care, halting clinical trials, and compounding long-standing systemic challenges.  Even before the war, Ukraine’s oncology system faced major constraints: Limited access to radiotherapy equipment, outdated chemotherapy supply chains, and workforce shortages. The invasion intensified these issues—cancer hospitals were damaged, warehouses destroyed,...

Patients affected by cancer are increasingly turning to artificial intelligence-powered chatbots, such as ChatGPT and Gemini, for answers to pressing health questions. These tools, available around the clock and free from geographic or scheduling constraints, are appealing when access to medical professionals is limited by financial, language, logistical, or emotional barriers. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login